Publications by authors named "Fatmah Dihowm"
J Clin Rheumatol
January 2025
Article Synopsis
- In a study of patients with systemic sclerosis (SSc), researchers examined the safety of musculoskeletal corticosteroid (MSKC) injections, focusing on the risk of scleroderma renal crisis (SRC).
- Out of 136 SSc patients, 46 received a total of 330 MSKC injections with no significant changes in vital signs, kidney function, or other health markers observed before and after the injections.
- The study concluded that MSKC injections are generally safe for established SSc patients, with a very low risk of SRC, although monitoring is advised for individuals at higher risk or with recent-onset SSc.
